ES2059181T3 - Uso de 1,4-dihidropiridinas para la fabricacion de un medicamento para el tratamiento de neuropatias causadas por diabetes mellitus. - Google Patents

Uso de 1,4-dihidropiridinas para la fabricacion de un medicamento para el tratamiento de neuropatias causadas por diabetes mellitus.

Info

Publication number
ES2059181T3
ES2059181T3 ES92112201T ES92112201T ES2059181T3 ES 2059181 T3 ES2059181 T3 ES 2059181T3 ES 92112201 T ES92112201 T ES 92112201T ES 92112201 T ES92112201 T ES 92112201T ES 2059181 T3 ES2059181 T3 ES 2059181T3
Authority
ES
Spain
Prior art keywords
dihydropyridids
manufacture
treatment
diabetes mellitus
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92112201T
Other languages
English (en)
Inventor
Jorg Dr Traber
Willem Hendrik Prof Dr Gispen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Application granted granted Critical
Publication of ES2059181T3 publication Critical patent/ES2059181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION CONCIERNE AL EMPLEO DE 1,4 A, PARA LA PRODUCCION DE MEDICAMENTOS PARA COMBATIR AFECCIONES EN NERVIOS PERIFERICOS, OCASIONADAS POR LA DIABETES.
ES92112201T 1991-07-30 1992-07-17 Uso de 1,4-dihidropiridinas para la fabricacion de un medicamento para el tratamiento de neuropatias causadas por diabetes mellitus. Expired - Lifetime ES2059181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125116A DE4125116A1 (de) 1991-07-30 1991-07-30 Verwendung von 1,4-dihydropyridinen bei diabetes

Publications (1)

Publication Number Publication Date
ES2059181T3 true ES2059181T3 (es) 1994-11-01

Family

ID=6437256

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92112201T Expired - Lifetime ES2059181T3 (es) 1991-07-30 1992-07-17 Uso de 1,4-dihidropiridinas para la fabricacion de un medicamento para el tratamiento de neuropatias causadas por diabetes mellitus.

Country Status (19)

Country Link
EP (1) EP0525537B1 (es)
JP (1) JP3381198B2 (es)
KR (1) KR930001908A (es)
AT (1) ATE111732T1 (es)
AU (1) AU659177B2 (es)
CA (1) CA2074709A1 (es)
CZ (1) CZ281712B6 (es)
DE (2) DE4125116A1 (es)
DK (1) DK0525537T3 (es)
ES (1) ES2059181T3 (es)
HU (1) HU208632B (es)
IE (1) IE65109B1 (es)
IL (1) IL102648A (es)
MX (1) MX9204423A (es)
NO (1) NO300253B1 (es)
RU (1) RU2043102C1 (es)
SK (1) SK238692A3 (es)
TW (1) TW202388B (es)
ZA (1) ZA925686B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863360A (en) * 1988-01-15 1989-09-05 Rogers Industrial Products Bag control mechanism for tire press

Also Published As

Publication number Publication date
CZ281712B6 (cs) 1996-12-11
NO922795D0 (no) 1992-07-15
EP0525537A1 (de) 1993-02-03
AU659177B2 (en) 1995-05-11
NO922795L (no) 1993-02-01
IE65109B1 (en) 1995-10-04
IL102648A (en) 1997-03-18
HUT63330A (en) 1993-08-30
JPH06157314A (ja) 1994-06-03
MX9204423A (es) 1993-01-01
HU9202484D0 (en) 1992-10-28
TW202388B (es) 1993-03-21
JP3381198B2 (ja) 2003-02-24
KR930001908A (ko) 1993-02-22
HU208632B (en) 1993-12-28
NO300253B1 (no) 1997-05-05
SK238692A3 (en) 1995-11-08
CZ238692A3 (en) 1994-01-19
EP0525537B1 (de) 1994-09-21
CA2074709A1 (en) 1993-01-31
DE59200530D1 (de) 1994-10-27
DK0525537T3 (da) 1995-02-20
IL102648A0 (en) 1993-01-14
ATE111732T1 (de) 1994-10-15
AU2048492A (en) 1993-02-04
RU2043102C1 (ru) 1995-09-10
IE922467A1 (en) 1993-02-10
ZA925686B (en) 1993-04-28
DE4125116A1 (de) 1993-02-04

Similar Documents

Publication Publication Date Title
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
ES2070628T3 (es) Uso de compuestos analogos a 1,3-oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
IL83842A0 (en) Benzo-fused cycloalkane and exa-and thia-,cycloalkane trans-1,2-diamine derivatives,their preparation and pharmaceutical compositions containing them
ES2091766T3 (es) Uso de n-butil-desoxinojirimicina para el tratamiento de herpes.
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
GB2223168B (en) Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes
ATE179073T1 (de) Asthma heilmittel
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
ES2059181T3 (es) Uso de 1,4-dihidropiridinas para la fabricacion de un medicamento para el tratamiento de neuropatias causadas por diabetes mellitus.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
ES2099736T3 (es) Utilizacion de derivados de la 15-deshidroxi-16-oxoprostaglandina en el tratamiento de las alergias.
DK256689A (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
ES2073871T3 (es) Tiazolidin-2,4-dionas en el tratamiento de la hipertension.
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
PT95757A (pt) Processo de preparacao de composicoes farmaceuticas a basede n-metil-2-(piridil-3)-tetra-hidrotiopirano-carbotioamida-2-oxido-1
DE69131521D1 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
ES2052634T3 (es) Utilizacion de la 2-(2-fenil-2-(2-piridil))etil-2-imidazolina o una sal de la misma para la preparacion de una composicion farmaceutica para el tratamiento y la prevencion del asma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 525537

Country of ref document: ES